Optimal warfarin management for the prevention of thromboembolic events in patients with atrial fibrillation : review of Canadian economic studies / Canadian Agency for Drugs and Technologies in Health.

Format:

Book

Author/Creator:

Canadian Agency for Drugs and Technologies in Health, author, issuing body.

Series:

CADTH optimal use report ; Number 1.2B.

CADTH Optimal Use Report ; Number 1.2B

Language:

English

Subjects (All):

Drugs--Cost effectiveness.

Drugs.

Drugs--Law and legislation.

Physical Description:

1 online resource.

Place of Publication:

Ottawa, ON : Canadian Agency for Drugs and Technologies in Health, 2011.

Summary:

The objective was to review the published literature for Canadian studies that provided information on the following question: What are the costs associated with specialized anticoagulation services?.

Contents:

ABBREVIATIONS

1. INTRODUCTION

1.1 COMPUS Expert Review Committee

2. CONTEXT AND POLICY ISSUES

3. RESEARCH QUESTION

4. KEY FINDINGS

5. METHODS

5.1 Literature Search Strategy

5.2 Selection Criteria

5.3 Data Extraction and Critical Appraisal Strategy

6. RESULTS

6.1 Quantity of Research Available

6.2 Review of Included Studies

7. DISCUSSION

7.1 Summary of Evidence

7.2 Limitations

8. CONCLUSIONS

REFERENCES

APPENDIX 1 EXPERT COMMITTEE AND CONTRIBUTORS

APPENDIX 2 DEFINITIONS OF ANTICOAGULATION MANAGEMENT SERVICES

APPENDIX 3 QUALITY ASSESSMENT USING BMJ CHECKLIST

APPENDIX 4 SUMMARY OF INCLUDED STUDIES

APPENDIX 5 SUMMARY OF SCHULMAN ET AL.

APPENDIX 6 SUMMARY OF LALONDE ET AL.

APPENDIX 7 SUMMARY OF BUNGARD ET AL.

Notes:

Description based on publisher supplied metadata and other sources.